"India’s specialty chemicals industry is a decadal growth opportunity and it is still not too late to participate in the value creation process. We prefer CRAMS/CSM players Navin Fluorine (Navin) and PI Industries (PI) as they provide long-term earnings visibility. We also like UPL due to robust growth outlook and reducing debt concerns and SRF due to rising contribution from the chemicals business," JM Financial research report.
KR Choksey's research report on Ami Organics
During Q4FY22, Ami Organics Ltd(AOL) reported revenue of INR 1,435 Mn (+54.47% YoY / +1.70% QoQ). For FY22 topline was up by 52.70% YoY. The growth was driven by Pharma Intermediate business followed by Specialty chemicals post acquisition of facilities from Gujrat Organics (GOL). On operational front EBITDA in Q4FY22 stood at INR 258 Mn (+10.78% YoY) but dipped marginally on QoQ basis by 13.57%, OPM saw a dip of 709bps YoY and 318 bps QoQ to 17.98% in Q4FY22. Margins fell on account of rising input costs. Net Profit in Q4FY22 stood at INR 213 Mn showing an improvement of 38.31% YoY and 9.23% QoQ, with NPM at 14.94%, marginal impact of 173bps on YoY basis and improved 102bps on QoQ basis. EPS during the quarter came at 6.22 against 4.89 in the same quarter last year. The company has declared a final dividend of INR 3 per share.
Outlook
We apply P/E multiple of 32.5x its FY24E earnings and thus continue to maintain our ‘BUY’ recommendation on the stock with the same target price of INR 1,229.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More